Skip to main content
. Author manuscript; available in PMC: 2011 Mar 15.
Published in final edited form as: Clin Cancer Res. 2010 Mar 9;16(6):1781–1789. doi: 10.1158/1078-0432.CCR-09-1913

Figure 2.

Figure 2

Effect of recombinant ShhN treatment on Gli1 mRNA expression in pancreatic CAFs. (a) Gli1 mRNA levels were assessed 24 hours after treatment of CAF27 cells with indicated concentrations of recombinant ShhN. (b) Comparison of ShhN treatment in control pancreatic fibroblasts and pancreatic CAFs. Gli1 mRNA levels were assessed 24 hours after treatment of HPNE, SC2, or CAF cells with indicated concentrations of recombinant ShhN. Relative Gli1 mRNA levels after normalization to the corresponding 18S rRNA levels are shown. Data are means of four independent experiments; bars are SD values.

HHS Vulnerability Disclosure